POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer Meeting Abstract


Authors: Kindler, H. L.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J.; Hochhauser, D.; Oh, D.; Reinacher-Schick, A.; Tortora, G.; Algül, H.; O'Reilly, E. M.; Bordia, S.; McGuinness, D.; Cui, K. Y.; Locker, G. Y.; Arnold, D.
Abstract Title: POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
Meeting Title: 52nd Meeting of the American Pancreatic Association
Journal Title: Pancreas
Volume: 50
Issue: 7
Meeting Dates: 2021 Nov 3-6
Meeting Location: Miami Beach, FL
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2021-08-01
Start Page: 1071
Language: English
ACCESSION: WOS:000706786400137
PROVIDER: wos
PUBMED: 34643612
DOI: 10.1097/MPA.0000000000001904
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly